Found: 30
Select item for more details and to access through your institution.
Ibalizumab: an anti-CD4 monoclonal antibody for the treatment of HIV-1 infection.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 9, p. 1839, doi. 10.1093/jac/dkq261
- By:
- Publication type:
- Article
1558. A Population Pharmacokinetic Model for Posaconazole Intravenous Solution and Oral Powder for Suspension Formulations in Pediatric Patients With Neutropenia.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S569, doi. 10.1093/ofid/ofz360.1422
- By:
- Publication type:
- Article
624. Molecular Characterization of Baseline Enterobacteriaceae and Pseudomonas aeruginosa from a Phase 3 Nosocomial Pneumonia (ASPECT-NP) Clinical Trial.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S289, doi. 10.1093/ofid/ofz360.692
- By:
- Publication type:
- Article
2227. Outcomes in Patients with Renal Impairment from a Phase 3 Clinical Trial for Ceftolozane–Tazobactam (C/T) Treatment of Nosocomial Pneumonia (ASPECT-NP).
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S760, doi. 10.1093/ofid/ofz360.1905
- By:
- Publication type:
- Article
2226. Impact of Prior and Concomitant Antibacterial Therapy on Outcomes in the ASPECT-NP Randomized, Controlled Trial of Ceftolozane/Tazobactam (C/T) vs. Meropenem (MEM) in Patients with Ventilated Nosocomial Pneumonia (NP).
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S760, doi. 10.1093/ofid/ofz360.1904
- By:
- Publication type:
- Article
Locating the Future of ESG: The Promise of Geospatial Data in Advancing ESG Research.
- Published in:
- Sustainability & Climate Change, 2023, v. 16, n. 1, p. 2, doi. 10.1089/scc.2022.0110
- By:
- Publication type:
- Article
Effect of lipophilicity on drug distribution and elimination: Influence of obesity.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 8, p. 3197, doi. 10.1111/bcp.14735
- By:
- Publication type:
- Article
Simon Peter in Scripture and Memory: The New Testament Apostle in the Early Church.
- Published in:
- 2013
- By:
- Publication type:
- Book Review
Outcomes in participants with failure of initial antibacterial therapy for hospital-acquired/ventilator-associated bacterial pneumonia prior to enrollment in the randomized, controlled phase 3 ASPECT-NP trial of ceftolozane/tazobactam versus meropenem.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Comparison between meropenem and ceftolozane/tazobactam: possible influence of CRRT.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Environmental, Social, and Governance (ESG) Outcomes and Municipal Credit Risk.
- Published in:
- Business & Society, 2024, v. 63, n. 8, p. 1709, doi. 10.1177/00076503231220541
- By:
- Publication type:
- Article
Germline Genetic Risk Variants for Progressive Multifocal Leukoencephalopathy.
- Published in:
- Frontiers in Neurology, 2020, v. 11, p. 1, doi. 10.3389/fneur.2020.00186
- By:
- Publication type:
- Article
The Whole Ugly Gorilla.
- Published in:
- 2016
- By:
- Publication type:
- Film/TV Criticism and Review
The Story of "The Story of a Novel": Discovering a Literary Artifact.
- Published in:
- 2004
- By:
- Publication type:
- Literary Criticism
Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial.
- Published in:
- Annals of Intensive Care, 2023, v. 13, n. 1, p. 1, doi. 10.1186/s13613-022-01084-8
- By:
- Publication type:
- Article
Thyroid Storm Caused by a Partial Hydatidiform Mole.
- Published in:
- Thyroid, 2008, v. 18, n. 4, p. 479, doi. 10.1089/thy.2007.0212
- By:
- Publication type:
- Article
Estimation of Absolute and Relative Body Fat Content Using Noninvasive Surrogates: Can DXA Be Bypassed?
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, p. S35, doi. 10.1002/jcph.2306
- By:
- Publication type:
- Article
Clinical Consequences of Altered Drug Disposition in Obesity: Call for Change.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, p. S25, doi. 10.1002/jcph.2308
- By:
- Publication type:
- Article
Ceftolozane/Tazobactam Probability of Target Attainment in Patients With Hospital‐Acquired or Ventilator‐Associated Bacterial Pneumonia.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 3, p. 352, doi. 10.1002/jcph.2165
- By:
- Publication type:
- Article
Probability of Target Attainment Analyses to Inform Ceftolozane/Tazobactam Dosing Regimens for Patients With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia and End-Stage Renal Disease Receiving Intermittent Hemodialysis.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 2, p. 166, doi. 10.1002/jcph.2149
- By:
- Publication type:
- Article
Drug Disposition in Subjects With Obesity: The Research Work of Darrell R. Abernethy.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 11, p. 1350, doi. 10.1002/jcph.2093
- By:
- Publication type:
- Article
Brexpiprazole Pharmacokinetics in CYP2D6 Poor Metabolizers: Using Physiologically Based Pharmacokinetic Modeling to Optimize Time to Effective Concentrations.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 1, p. 66, doi. 10.1002/jcph.1946
- By:
- Publication type:
- Article
Impact of Obesity on Brexpiprazole Pharmacokinetics: Proposal for Improved Initiation of Treatment.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 1, p. 55, doi. 10.1002/jcph.1947
- By:
- Publication type:
- Article
Population Pharmacokinetic Analysis for Plasma and Epithelial Lining Fluid Ceftolozane/Tazobactam Concentrations in Patients With Ventilated Nosocomial Pneumonia.
- Published in:
- Journal of Clinical Pharmacology, 2021, v. 61, n. 2, p. 254, doi. 10.1002/jcph.1733
- By:
- Publication type:
- Article
Ceftolozane/tazobactam probability of target attainment and outcomes in participants with augmented renal clearance from the randomized phase 3 ASPECT-NP trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Ceftolozane/tazobactam versus meropenem in patients with ventilated hospital-acquired bacterial pneumonia: subset analysis of the ASPECT-NP randomized, controlled phase 3 trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Ceftolozane/tazobactam for hospital-acquired/ventilator-associated bacterial pneumonia due to ESBL-producing Enterobacterales: a subgroup analysis of the ASPECT-NP clinical trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia.
- Published in:
- 2022
- By:
- Publication type:
- journal article
READERS, AUTHORS, AND THE DIVINE AUTHOR: AN EVANGELICAL PROPOSAL FOR IDENTIFYING PAUL'S OLD TESTAMENT CITATIONS.
- Published in:
- Westminster Theological Journal, 2009, v. 71, n. 2, p. 311
- By:
- Publication type:
- Article
Students' Willingness to Pay for More Local, Organic, Non-GMO and General Food Options.
- Published in:
- Journal of Food Distribution Research, 2016, v. 47, n. 3, p. 32
- By:
- Publication type:
- Article